ANKRD17 and hyperlipidemia: The strongest associations (Plead variant < 10−100, Bayes factor (BF)CS > 10100) for hyperlipidemia medications were in established lipid loci (APOE, LDLR, PCSK9, APOC1, CBLC and ANKRD17).